Macquarie Group’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-292
Closed -$6.64K 2428
2022
Q2
$6K Hold
292
﹤0.01% 2506
2022
Q1
$6 Hold
292
﹤0.01% 2574
2021
Q4
$8K Hold
292
﹤0.01% 2535
2021
Q3
$8K Hold
292
﹤0.01% 2563
2021
Q2
$8K Hold
292
﹤0.01% 2492
2021
Q1
$7K Sell
292
-138
-32% -$3.29K ﹤0.01% 2427
2020
Q4
$9K Hold
430
﹤0.01% 2312
2020
Q3
$9K Hold
430
﹤0.01% 2291
2020
Q2
$10K Buy
+430
New +$9.96K ﹤0.01% 2289
2019
Q1
Sell
-900
Closed -$22K 1827
2018
Q4
$22K Sell
900
-1,540
-63% -$39.9K ﹤0.01% 1773
2018
Q3
$76K Sell
2,440
-9,360
-79% -$280K ﹤0.01% 1646
2018
Q2
$322K Buy
+11,800
New +$313K ﹤0.01% 1503

Other funds holding HSTM

Macquarie Group's HSTM Position: Q3 2022 in Review

Macquarie Group sold out of HealthStream (HSTM) in Q3 2022, closing a stake of 292 shares — an estimated $6.64K sold.

Macquarie Group first reported a position in HSTM in Q2 2018 and held it in 12 quarters. The position peaked at $322K in Q2 2018. 158 funds tracked by Wall St. Rank hold HSTM as of Q3 2022.

  • Macquarie Group reported no remaining HealthStream position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 292 HealthStream shares in Q3 2022, an estimated $6.64K.
  • Macquarie Group first reported a position in HealthStream in Q2 2018 and held it in 12 quarters.
  • Macquarie Group's HealthStream position peaked at $322K in Q2 2018.
  • 158 funds tracked by Wall St. Rank held HealthStream as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.